Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16155611 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Conditions: Adult T Cell Leukemia;   Adult T Cell Lymphoma
Interventions: Drug: IMTOX-25;   Other: IMTOX-25

Indicates status has not been verified in more than two years